Xiao Lan Yang
Directeur/Bestuurslid bij Shanghai Genext Medical Technology Co., Ltd.
Profiel
Xiao Lan Yang is currently the Director & Deputy General Manager at Shanghai Genext Medical Technology Co., Ltd.
She started this position in 2020.
Prior to her current role, she has a background in education.
She graduated from the University of Lyon and obtained an undergraduate degree from Shanghai Medical College of Fudan University.
She also holds an MBA from Olin Business School and Fudan University School of Management.
Actieve functies van Xiao Lan Yang
| Bedrijven | Functie | Begin |
|---|---|---|
Shanghai Genext Medical Technology Co., Ltd.
 Shanghai Genext Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Genext Medical Technology Co., Ltd. provides medical device products and services in the field of organ transplantation. It mainly supplies equipment for organ preservation, transportation, evaluation, and repair; medical consumables; and personalized diagnostic reagents for transplant patients. The company was founded on March 25, 2003 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 01-04-2020 |
Opleiding van Xiao Lan Yang
| Shanghai Medical College of Fudan University | Undergraduate Degree |
| University of Lyon | Graduate Degree |
| Fudan University School of Management | Masters Business Admin |
| Olin Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Shanghai Genext Medical Technology Co., Ltd.
Shanghai Genext Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Genext Medical Technology Co., Ltd. provides medical device products and services in the field of organ transplantation. It mainly supplies equipment for organ preservation, transportation, evaluation, and repair; medical consumables; and personalized diagnostic reagents for transplant patients. The company was founded on March 25, 2003 and is headquartered in Shanghai, China. | Health Technology |
